dean kamen, joining us. >> i look forward to it. >> and walter isaacson. you. >>> let's bring in simon hobbs. >> this is a really strong close we have in europe. check out the detail on the map. two major things coming through. the brent is settling higher above $85 a battle. and a thes a boosted norway. periphery, greece is up over 5%. the market running with this report from reuters that the european central bank is preparing to buy corporate bonds across europe as early as december. -- it may have some validity. there are some a lot of research notes out. rbs says if they do it they will likely buy more than what the bank of england did, 1% of corporate bonds as a high rated level of the market. they are likely to target euro denominated bonds from international companies as well as those around europe. check out some italian players. and certainly it is capped had rising yields. the italian bond market yields have been rising. it's just been table support the market there. greek banks doing were vel well. they may free up 240 billion euros of bailout c

i'm pleased to be here and thank you for the opportunity. >> i'm dean kamen.e last few decades, as everybody in this room is aware. i'm concerned that the pace at which technology is developing is increasing. we're in the 21st century and accelerating. the pace at which the systems around us are moving makes us feel like we're trapped in a 19th century model trying to deal with 21st century opportunities. again over the next few hours i'd like to maybe talk about a few of them, but a list of things that i think should be noncontroversial that could help things go better since, as michael milken has said more than once, the whole issue is time and money. we've got to shorten the time and reduce the cost. if cms, fda and all the other agencies that are part of the chain of events could work together so that we could, for instance, in parallel do all the work we need to do as industry to deal with cms and reimbursement at the same time as we go through the fda process, things would get faster and simpler and cheaper. another issue, which i hope is noncontroversia

a few weeks later he won his first award in stephen kamen gave him the award. incomprehensibly he talked about he rejected the role so long and he finally said yes and it was so great. cedeno gets up and said i don't reject everything. when doris goodwin afscme to go been a streaky weather, i accepted out once. [laughter] was a "wall street journal" reporter there was in the paper next day, so as a, so it's a great adventure. i saw this man walked away like and want only because someone told us he walked like a labor coming off the end of a hard day. he talked with a high-pitched voice we knew because someone told. he had the sense of humor. he told the stories. he was melancholy and i truly felt the lincoln i knew had come to life. >> or book covers much of lincoln's life. were you surprised the movie only covers about four pages of the book on the 13th amendment. we disappointed a small knot was covered or you thought that was appropriate? >> on the contrary, when he started he had 600 pages and it covered more of the book and then it got down to 500 pages. b

dean kamen is the inventor of the cybercom who most recently as been working on it prosthetic arm in for injured veterans that can be controlled by the printer is also the founder of first, national competition that encourages students to pursue a life in science and technologies being described after morgan freeman, let's take a 30-second look. >> this is the super bowl. the super bowl of smart, that is. it's a life-changing competition. students having fun, competing, working together to dream up, design and build robots. spent it's an exhilarating feeling. i'm using power tools. >> having the hardest on they will ever have, and they are becoming our next generation of engineers and innovators. >> for inspiration and recognition of science and technology,. >> please welcome to the stage deka research in the public corporation founder, dean kamen, and the atlantic's rebecca rosen. [applause] >> thank you. >> hi. thank you so much for joining here. why don't we just start by you talking about first what it is, why you started it and what you seem in the years since it began? >> let m